Predicting Long-Term Prognoses and Grading Platinum Sensitivity Using a Novel Progression-Free Interval Criterion in...

Area of Science:

• Oncology
• Gynecologic Oncology
• Clinical Research

Background:

• Ovarian clear cell carcinoma (OCCC) prognosis is influenced by platinum sensitivity.
• Accurate grading of platinum sensitivity is crucial for treatment stratification.
• Long-term prognostic predictors in OCCC require further elucidation.

Purpose of the Study:

• To identify long-term prognostic predictors for ovarian clear cell carcinoma.
• To establish progression-free interval (PFI) criteria for grading platinum sensitivity in OCCC.
• To evaluate factors influencing disease progression and survival in OCCC patients.

Main Methods:

• Retrospective review of 536 ovarian clear cell carcinoma patients' medical records from nine tertiary centers (1995-2015).
• Analysis of patient characteristics, therapeutic factors, clinical outcomes, and hazard ratios.
• Development of new progression-free interval (PFI) distributions (seven and 14 months) for platinum sensitivity grading.

Main Results:

• Preoperative CA125 levels and chemotherapy response independently predicted early-stage progression-free survival (PFS) risk.
• A PFI <7 months strongly predicted post-progression mortality and relapse, correlating with chemo-resistance and advanced stage.
• Post-progression cytoreduction was associated with reduced mortality risk.

Conclusions:

• Progression-free interval (PFI) criteria can effectively grade platinum sensitivity in OCCC.
• A PFI <7 months indicates chemo-resistance and poor prognosis, necessitating novel therapeutic strategies.
• Targeted agents and biomarkers for chemo-resistance should be investigated for advanced OCCC and early progression cases.